Interação entre inflamação sistêmica e local na artrite reumatoide: evidências a partir do fluido crevicular gengival
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Introduction: Gingival crevicular fluid (GCF) is a relevant indicator in detecting
periodontal inflammation, especially in subclinical stages and in patients with chronic
diseases such as Rheumatoid Arthritis (RA). Objective: To quantitatively assess GCF,
periodontal condition, and clinical parameters of Rheumatoid Arthritis (RA), comparing
them to a control group (CG), and to verify the correspondence between systemic and
dental aspects. Methodology: A cross-sectional study was conducted with consecutive
RA patients treated at a public university hospital and controls matched by age, sex,
and socioeconomic status. Demographic data, RA activity, functional capacity,
anticholinergic burden, socioeconomic status, polypharmacy (PP), orofacial physical
examination, and complete periodontal evaluation were assessed. GCF volume was
measured using a Periotron® (Oralflow Inc., New York, NY, USA). Statistical analysis
included parametric and non-parametric tests, as well as multiple correspondence
analysis (MCA), with significance set at p<0.05. Results: A total of 33 patients were
evaluated, 18 in the RA group and 15 in the control group. The mean age was 55 years
in the RA group and 42 in the control group. Regarding the periodontal condition, 9
(50%) RA patients were diagnosed with periodontitis, with mean probing depth index
(PDI) of 4%, plaque index (PI) 25.5%, and bleeding on probing (BOP) 30%. In contrast,
12 (80%) controls were diagnosed with gingivitis, with mean PDI of 1%, PI 32%, and
BOP 34%, revealing worse periodontal status in RA patients, although GCF levels
were similar between groups. The multivariate correspondence analysis showed a
strong association between advanced periodontitis (stages III/IV grade B), high biofilm
indices (PI >20%), gingival bleeding (BOP >10%), pocket depth >4 mm, and severe
gingival inflammation (GCFs). These conditions coincided with higher rheumatologic
activity (DAS28h), severe functional impairment (HAQs), use of biologics (bDMARDs),
polypharmacy, and elevated anticholinergic activity (ADS≥3). Conversely, individuals
with periodontal health and RA in remission showed low local and systemic
inflammatory levels, less medication use and absence of immunosuppressive therapy.
Intermediate cases were positioned between these extremes, indicating gradual
progression and interdependence between oral and systemic manifestations.
Conclusion: RA patients demonstrated greater periodontal impairment despite similar
GCF levels compared to controls. Multivariate analysis revealed a strong association
between periodontal severity, RA activity, polypharmacy, and elevated anticholinergic
activity. Even with a limited number of patients, the findings highlight underexplored
data in scientific literature, reinforcing the importance of integrated evaluation of
systemic and oral conditions, and suggesting that GCF volume is implicated in the
pathophysiological mechanisms of periodontal disease progression in RA.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Embargado

